Parallax Volatility Advisers, L.P. Viatris Inc Call Options Transaction History

Parallax Volatility Advisers, L.P.

14 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	BUY	$11.27 - $13.53 $120,589 - $144,771	10,700 New	10,700 $127,000
Q1 2023 May 15, 2023	SELL	$9.2 - $12.26 $23.8 Million - $31.7 Million	-2,581,700 Reduced 97.94%	54,200 $521,000
Q4 2022 Feb 14, 2023	BUY	$8.72 - $11.56 $5.16 Million - $6.84 Million	591,300 Added 28.92%	2,635,900 $29.3 Million
Q3 2022 Nov 14, 2022	BUY	$8.48 - $11.13 $3.11 Million - $4.09 Million	367,300 Added 21.9%	2,044,600 $17.4 Million
Q2 2022 Aug 15, 2022	SELL	$9.95 - $12.27 $309,445 - $381,597	-31,100 Reduced 1.82%	1,677,300 $17.6 Million
Q1 2022 May 16, 2022	BUY	$9.81 - $15.4 $16.8 Million - $26.3 Million	1,708,400 New	1,708,400 $18.6 Million
Q4 2021 Feb 14, 2022	BUY	$12.09 - $14.68 $4.87 Million - $5.92 Million	403,028 Added 88.58%	858,028 $11.6 Million
Q4 2021 Feb 14, 2022	SELL	$12.09 - $14.68 $10.4 Million - $12.6 Million	-858,028 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$13.25 - $15.13 $6.03 Million - $6.88 Million	455,000 New	455,000 $6.17 Million
Q3 2021 Nov 15, 2021	SELL	$13.25 - $15.13 $2.05 Million - $2.34 Million	-154,400 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$12.97 - $16.15 $2 Million - $2.49 Million	154,400 New	154,400 $2.21 Million
Q1 2021 May 14, 2021	SELL	$13.59 - $18.54 $1.78 Million - $2.43 Million	-130,996 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$13.59 - $18.54 $8.46 Million - $11.5 Million	-622,368 Reduced 82.61%	130,996 $1.83 Million
Q4 2020 Feb 16, 2021	BUY	$14.3 - $18.74 $10.8 Million - $14.1 Million	753,364 New	753,364 $14.1 Million

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.2B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.